Evaluation of Safety of Repeated Doses of OP0201 Metered Dose Inhaler Compared to Placebo in Healthy Adult Volunteers

Completed · Phase 1 · Has a placebo group

Conditions studied: Healthy Adult Volunteers

In brief

The purpose of this study is to evaluate the safety and tolerability of two dose levels of OP0201 and placebo, when administered intranasally in healthy adults subjects.

Key facts

Study ID
NCT03748758
Run by
Novus Therapeutics, Inc
People needed
30
Starts
2018-11-27
Expected to finish
2019-03-20
Last updated by the study team
2020-02-25

Who can join

Age: 18 and older, up to 50. Sex: any. Healthy volunteers: accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.